Cervical carcinoma: Oncobiology and biomarkers

Cervical cancer is one of the most common types of carcinomas causing morbidity and mortality in women in all countries of the world. At the moment, the oncology, oncobiology, and on-comorphology of cervical cancer are characterized by the accumulation of new information; various molecular biological, genetic, and immunohistochemical methods of investigation of the mechanisms of cervical carcinogenesis are tested and applied; targeted antitumour drugs and diagnostic, prog-nostic, and predictive biomarkers are being searched for. Many issues of the etiopathogenesis of cervical cancer have not been sufficiently studied, and the role of many biomarkers characterizing various stages of cervical carcinogenesis remains unclear. Therefore, the target of this review is to systematize and understand several problems in the pathogenesis of cervical cancer and to evaluate the significance and role of biomarkers in cervical carcinogenesis. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Authors
Volkova L.V.1 , Ilexander P.A.2 , Nadezhda O.N. 3
Publisher
MDPI AG
Number of issue
22
Language
English
Status
Published
Number
12571
Volume
22
Year
2021
Organizations
  • 1 Laboratory of Immunohistochemistry, Pathology and Clinical Diagnostics, Department of Fundamental Medicine, Medical Institute, Immanuel Kant Baltic Federal University, Kaliningrad, 236041, Russian Federation
  • 2 Department of Obstetrics and Gynecology, Medical Institute, Immanuel Kant Baltic Federal, Kaliningrad, 236041, Russian Federation
  • 3 Department of Clinical Laboratory Diagnostics, Faculty of Continuing Medical Education, People’s Friendship University, Moscow, 117198, Russian Federation
Keywords
Biomarkers; Carcinoma of the cervix; Cervical carcinogenesis; Immunohistochemistry
Date of creation
16.12.2021
Date of change
16.12.2021
Short link
https://repository.rudn.ru/en/records/article/record/76513/
Share

Other records